CoreCivic (CXW) Q3 2026 earnings review
CoreCivic's per-share profit doubles, but its facility margins stay flat
CoreCivic, an operator of private prisons and detention centers, turned four property sales into fast per-share profit growth while its facility margins stood still. Revenue rose 28%, and profit per share excluding one-offs more than doubled after the company used $1.6 billion in sale proceeds to pay off debt and buy back 14% of its shares. New chief executive Lucibeth Mayberry raised the full-year operating outlook, though by our math the plan has fourth-quarter Adjusted EBITDA stepping down 9% from the third quarter.
| Revenue | $744.1M +28.2% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $0.49 +104.2% from a year ago |
| Residential occupancy | 84.0% 76.7% a year ago |
| Full-year profit per share outlook | Raised $0.09 middle of the range: $1.77 (+61%) |
⚖️ Verdict: 🟢 Bullish
The story got better because the company followed through on its cash windfall and filled 84% of its beds. After buying zero shares in the second quarter, CoreCivic retired 12.4 million shares in August, wiped out its net debt, and added $500 million to its buyback plan. One caution: higher bed use did not lift the Residential operating margin, which stayed at 22.3% as start-up costs at newly reopened sites offset the extra detainees.
The question now is whether selling detention centers to the federal government unlocks hidden property value or turns CoreCivic into a lower-margin contractor on terms the buyer sets. If it unlocks value, cash returns and high bed occupancy will keep lifting per-share earnings; if the buyer squeezes fees, operating profit will drop once the contracts on the four sold sites are rewritten. The finalized contract terms and fourth-quarter facility margins will tell.
🐂 Bull Case
Facility Sales Wiped Out Net Debt
CoreCivic, an owner and operator of private prisons and detention centers, turned four properties into cash during the third quarter. It sold the facilities to the Department of Homeland Security for $2.2 billion, leaving $1.6 billion after taxes and fees. Chief executive Lucibeth Mayberry said, "Our balance sheet has improved meaningfully and provides us significant flexibility with both our capital allocation strategy and growth plans."
- Debt repaid: over $700 million, cutting total debt to $630 million and leaving cash slightly above debt
- Net interest expense: $7.0 million, down 58% from $16.6 million a year ago
- Share buybacks: $500 million paid under an accelerated repurchase deal, cutting diluted shares by 13.8% from a year ago
- Buyback capacity: the board added $500 million on November 3, leaving $756 million available
The numbers back Mayberry's claim because lower interest bills and fewer shares turned a 32.6% rise in Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, excluding one-offs) into a 104.2% jump in per-share profit. After buying zero shares in the second quarter during deal talks, the prison operator retired 12.4 million shares in August.
What to watch: open-market share purchases in the fourth quarter and preliminary talks with U.S. Immigration and Customs Enforcement (ICE) to buy more facilities. Additional buybacks from the $547 million cash pile would lift next year's per-share profit even if operating earnings flatten.
Occupancy Reached 84% on Higher Federal Demand
CoreCivic's Residential segment, which houses detainees and inmates for government agencies, relies on federal immigration enforcement and state prison budgets to fill its beds. In the third quarter, Residential occupancy rose to 84.0%, up from 78.4% in the second quarter and 76.7% a year ago.
Higher detainee counts at ICE facilities and higher daily rates (per-diem increases) lifted federal Residential revenue by 22.2%, or $71.3 million, from a year ago. In August, the detention operator also won a five-year ICE contract to reopen the 1,600-bed Appleton facility in Minnesota, which it expects to generate $75 million in yearly sales once full in the second quarter of 2027.
What to watch: the exact quarter-end count of ICE detainees in CoreCivic's care and the daily revenue per detainee in the quarterly filing. A detainee count above 16,197 from June would confirm that rising bed use is continuing into year-end.
The Pharmacy Acquisition Lifted Services Operating Profit
CoreCivic Services provides non-housing services to correctional agencies, including prisoner transportation, electronic monitoring, and Clinical Solutions Pharmacy (CSP), a mail-order prison pharmacy bought in April 2026. The company created this segment to rely less on government detention beds.
Segment net operating income (revenue minus facility operating expenses) reached $9.6 million in the third quarter, up from $9.0 million in the second quarter and $1.1 million a year ago. However, CoreCivic also recorded a $22.1 million one-off accounting gain from lowering the performance payout (contingent consideration) owed to CSP's sellers, which suggests the pharmacy is tracking below its highest 2026 payout targets.
What to watch: Services segment revenue before internal sales between CoreCivic divisions are removed, disclosed in the quarterly filing. A sequential rise from $88.7 million in the second quarter would show the pharmacy is winning outside customers despite the reduced payout estimate.
🐻 Bear Case
Higher Occupancy Did Not Lift Facility Margins
Running detention centers has fixed staffing and building costs, so filling more beds should widen profit margins. After the second quarter, CoreCivic expected its Residential operating margin to rise in the second half of 2026 as four newly reopened facilities filled up.
Occupancy jumped 5.6 percentage points from the second quarter to 84.0%, but the Residential operating margin stayed flat at 22.3%, down from 22.4% in the second quarter and 22.5% a year ago. Across the whole company, facility operating expenses — the cost of staffing and running sites — rose by 1.4 percentage points of revenue from a year ago, to 78.9%.
CoreCivic said the margin stayed flat "because these four facilities continue to be in various stages of activation, they are not yet contributing at a fully activated margin percentage". Yet net operating income at those four sites fell to $19.9 million in the third quarter from $21.1 million in the second quarter, by our math, showing that start-up staffing costs are eating into the revenue gains.
What to watch: Residential operating margin in the fourth quarter as the 1,600-bed Appleton facility begins hiring staff and taking detainees. Another reading near 22% would show that continuous facility openings are capping the profit margin of the core business.
Contracts on Sold Facilities Remain Unsettled
When the federal government bought four detention centers in July and August, CoreCivic kept operating them under its existing agreements. Because the government now owns the buildings, it no longer needs to pay the operator for real-estate ownership, and CoreCivic warned that the contracts will change.
Three months after the sales closed, the two sides "have not yet modified the management contracts for these facilities to reflect the change in ownership", the company said. Meanwhile, the detention group is in talks with ICE to sell more facilities, though talks are "in preliminary stages, and we can provide no assurance that any additional facility sales will occur". By our math, the full-year outlook points to fourth-quarter Adjusted EBITDA of $106.7 million, down 9.4% from the third quarter, which builds in an undisclosed hit from the pending fee cuts.
What to watch: the finalized fee terms on the four sold facilities and the 2027 renewal of the California City and Midwest contracts, which both expire in August 2027. A sharp drop in fourth-quarter facility profit would show how much earnings power CoreCivic gives up when it trades property ownership for management fees.
Risks this quarter didn't answer
Several standing customer, legal, and property risks received no new figures in the third-quarter earnings release and await the quarterly filing.
- Single-customer reliance: federal agencies made up 53% of revenue, led by ICE, leaving the business exposed to federal budget disputes and policy shifts after 2029.
- U.S. Marshals revenue: fell $14.1 million from a year ago in the second quarter; the release combined ICE and Marshals revenue without breaking out whether the Marshals decline continued.
- Lawsuits and federal probes: detainee class-action suits at Otay Mesa, an injunction case at California City, and a Justice Department investigation at Trousdale Turner got no status updates.
- Elizabeth Detention Center lease: the ICE operating contract runs to May 2031, but CoreCivic's lease on the building from a private landlord expires in June 2027.
👓 Other Themes
Chief Executive Step-Down and Higher Overhead Costs
On September 24, chief executive Patrick Swindle stepped down "due to health reasons" after less than nine months in the role, and the board named strategy chief Lucibeth Mayberry to replace him. Mayberry committed to "executing our strategy, which remains unchanged". The transition added $6.4 million in settlement pay, while general and administrative overhead — corporate pay, bonuses, and technology — rose 24.6% from a year ago to $56.4 million (7.6% of revenue).
💲 Other KPIs
Normalized Funds From Operations — cash earnings from real estate and operations, excluding property sale gains and one-off charges — rose 34.3% from a year ago, or 56.3% per share. Growth sped up from 8.5% per-share growth in the second quarter as facility activations, debt paydowns, and the August share buyback took effect.
Bills owed by government customers rose 15.6% from the second quarter and 20.0% from the end of 2025, outpacing the 8.6% quarterly revenue increase. The reserve for unpaid bills also grew to $7.8 million from $5.6 million in June and $4.5 million at year-end, tying up working capital as federal billing expands.
CoreCivic trimmed its full-year spending plan on other capital investments by $3 million to $12 million. It kept real-estate maintenance at $30–35 million, technology and other maintenance at $35–40 million, and facility activation spending at $35–40 million, down from $171.5–179.5 million planned across all categories in 2025.
🔮 Guidance
Raised. The middle of the full-year plan moved up $7 million from the post-August update, to 21.4% growth over 2025. By our math, that leaves $106.7 million for the fourth quarter, down 9.4% from the third quarter and up 15.3% from a year ago, as pending contract changes on the four sold facilities and Appleton start-up costs weigh on year-end earnings.
Raised. The middle of the range rose 8.5 cents, pointing to 60.9% growth for the year. By our math, the outlook leaves $0.48 per share for the fourth quarter, almost even with $0.49 in the third quarter and up 77.8% from a year ago. It is the fourth raise this year: +$0.04, +$0.08, +$0.025, and +$0.085.
Raised. The middle of the range rose $7 million to $168.0 million, or 41.2% growth over 2025. By our math, that leaves $45.0 million for the fourth quarter, slightly below $45.7 million in the third quarter and up 60.1% from a year ago, supported by lower interest expense after the August debt redemptions.
Raised. The middle of the range moved up 9 cents to $2.815 per share, or 37.3% growth for the year. By our math, that leaves about $0.735 per share for the fourth quarter, compared with $0.75 in the third quarter and up 41.3% from a year ago.
Raised. The middle of the range rose 18 cents to $2.885 per share, or 42.8% growth over 2025. The gap above Normalized FFO reflects the $22.1 million one-off accounting gain from lowering the pharmacy acquisition payout estimate, which stays inside standard FFO.
Cut. The middle of the unadjusted profit outlook fell by $37.5 million because the final pre-tax gain on the four facility sales came in at $1.771 billion rather than the $1.785–1.800 billion estimated in August, alongside higher tax provisions on the special items.
Cut. The middle of the unadjusted per-share range moved down 27 cents to $15.45, reflecting the smaller final accounting gain and higher tax expense on the four property sales, partly offset by the lower share count.
Unchanged. The middle of the unadjusted EBITDA range slipped $3.5 million to $2.223 billion as the final real-estate sale gain and the pharmacy payout adjustment offset one another.
❓ Key Questions
Why did lowering the pharmacy payout add $22 million?
CoreCivic booked a $22.1 million gain from contingent consideration on the Clinical Solutions Pharmacy deal. Since the April purchase included a $51.8 million estimated payout based on 2026 financial targets, cutting that liability by 43% suggests the pharmacy is missing its initial growth goals.
When will ICE modify the four sold facility contracts?
Three months after selling four detention centers to the federal government, the operating contracts still have not been modified to remove the property-ownership return. Investors need to know how much quarterly profit the fourth-quarter outlook removes for these pending contract changes.
Why did profit drop at the four activating facilities?
Net operating income at the four activating facilities slipped to $19.9 million in the third quarter from $21.1 million in the second quarter even as overall Residential occupancy reached 84%. Management did not explain which facility saw higher costs or slower intake.
What were the quarter-end ICE population and Services sales?
The earnings release did not include the quarter-end count of ICE detainees in CoreCivic's care or Services segment revenue before internal eliminations. Those two figures in the quarterly filing will show whether federal bed demand and outside pharmacy sales are growing on their own.